ClinicalTrials.Veeva

Menu

Strengthening the Connections to Opportunities for Prevention Engagement (SCOPE)

K

Kevin Borrup

Status

Enrolling

Conditions

Interpersonal Violence
Structural Violence

Treatments

Other: Treatment as usual
Other: Active Case Management

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The Strengthening the Connections to Opportunities for Prevention Engagement (SCOPE) project will create a pathway for children and families from the City of Hartford to connect with a Connecticut Children's Care Coordinator (CC) in an effort to reduce levels of violence exposure.

Full description

The Strengthening the Connections to Opportunities for Prevention Engagement (SCOPE) project will create a pathway for children and families from the City of Hartford to connect with a Connecticut Children's Care Coordinator (CC) when they are determined to have high levels of violence exposure.

SCOPE seeks to decrease future violence exposure and increase resiliency of children with high levels of exposure to violence through Emergency Department (ED)-based case management and connections with community partners.

Hypothesis 1: VPET scores within the intervention group will show significant reductions across the study period. The percent of patients with positive VPET positive scores within the intervention group will show significant reductions from the expected 79% to 70% as compared to the control group that will have the expected 79%

Hypothesis 2: The Child and Youth Resilience Measure-Revised (CYRM) scores for the intervention group will increase by 10%, and will be significantly higher than the control group.

Hypothesis 3: At least 75% of the intervention group will be assessed as "positive" for having made a connection with community services.

Hypothesis 4: 90% of parents with children receiving case management will report being satisfied with the case management services and community connected services.

Hypothesis 5: Retention within the intervention group will be at or above 50%, with at least half of participants remaining engaged in the project.

Hypothesis 6: Compared to the control group, the intervention group will have fewer documented injuries and ED visits during the 12-month period post-enrollment.

Enrollment

225 estimated patients

Sex

All

Ages

8 to 17 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • At least 8 years of age and not older than 17 years of age (until 18th birthday)
  • Hartford resident based on zip code of primary residence or parent report?
  • Accompanied by a parent or guardian who can provide consent
  • Capable of providing assent/consent
  • Able to provide consent in English or Spanish
  • Presenting at CT Children's during recruitment hours

Exclusion criteria

  • Patients whose primary complaint is for behavioral health
  • Patients in Connecticut Department of Children and Families (DCF) or police custody

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

225 participants in 2 patient groups

Intervention
Experimental group
Description:
Enrolled subjects will provide the study team with email, mobile, work phone, physical contact address, and contact numbers for two or more close contacts. Families will be contacted monthly by the case manager assist with additional supports they might need. Quarterly, patients and families will be contacted and patients will be asked to complete VPET and other measures. The intervention group will receive active case management to connect affected youth to community services.
Treatment:
Other: Active Case Management
Other: Treatment as usual
Treatment as Usual
Active Comparator group
Description:
The comparison group will receive treatment as usual which consists of a list of community resources and a recommendation that youth not already connected with a community service provider be connected.
Treatment:
Other: Treatment as usual

Trial contacts and locations

1

Loading...

Central trial contact

Sharon Smith, MD; Rebecca Beebe, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems